Surgical management of novacor drive-line exit site infections

Michael K. Pasque, Tina Hanselman, Kim Shelton, Beth A. Kehoe-Huck, Robyn Hedges, Stephen D. Cassivi, Gregory A. Ewald, Joseph G. Rogers

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.

Original languageEnglish (US)
Pages (from-to)1267-1268
Number of pages2
JournalAnnals of Thoracic Surgery
Volume74
Issue number4
DOIs
StatePublished - Oct 1 2002

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Pasque, M. K., Hanselman, T., Shelton, K., Kehoe-Huck, B. A., Hedges, R., Cassivi, S. D., Ewald, G. A., & Rogers, J. G. (2002). Surgical management of novacor drive-line exit site infections. Annals of Thoracic Surgery, 74(4), 1267-1268. https://doi.org/10.1016/S0003-4975(02)03752-9